• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 14 DAY; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 14 DAY; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71940-01
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Erythema (1840); Unspecified Infection (1930); Itching Sensation (1943); Burning Sensation (2146)
Event Date 10/11/2019
Event Type  Injury  
Manufacturer Narrative
The product has been requested back for an investigation.A follow-up report will be submitted once additional information is obtained.The device mfg date is unknown.The date entered is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
Customer reported experiencing a skin reaction while wearing an adc freestyle libre sensor and experienced symptoms described as a red, itchy, burning skin infection.Customer had contact with a healthcare professional and received an unspecified antibiotic for treatment.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
No product has been returned and a valid serial number has not been provided.Extended investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.The reported complaint is related to skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.Dose audit reports were reviewed and demonstrated the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.Clinical data was reviewed and confirmed that freestyle libre sensor continue to be safe, effective, and perform as intended in the field.A tripped trend review was completed for the reported complaint and fs libre sensors, and there were no adverse trends that indicate any potential product related issues.If the product is returned, the case will be re-opened and a physical investigation will be performed.
 
Event Description
Customer reported experiencing a skin reaction while wearing an adc freestyle libre sensor and experienced symptoms described as a red, itchy, burning skin infection.Customer had contact with a healthcare professional and received an unspecified antibiotic for treatment.There was no report of death or permanent injury associated with this event.
 
Event Description
Customer reported experiencing a skin reaction while wearing an adc freestyle libre sensor and experienced symptoms described as a red, itchy, burning skin infection.Customer had contact with a healthcare professional and received an unspecified antibiotic for treatment.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
This mdr is intended as a follow up as the customer recently returned seven sensors to adc.The received sensors are: (b)(4).At the time of the reported event, the customer was not able to indicate a specific serial number, therefore, it is unknown which, if any, of the returned sensors were actually related to the medical event.However, investigations were performed for each of the returned sensors and the investigation for each of the returned sensors is as follows: partial products were returned for each of the listed serial numbers.The returned parts for each sensor serial number were the sensor patch, puck, and plug.Visual inspections were performed on the returned parts for each sensor serial number and no issues were observed.Dhrs (device history review) for the freestyle libre sensor kit were reviewed for each serial number and the dhrs showed the freestyle libre sensor kits passed all tests prior to release.Dose audit reports were reviewed for each sensor serial number and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed for each sensor serial number, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.There was no indication that the product did not meet specification.If the applicators and sharps are returned, the case will be re-opened, and further physical investigation will be performed.All pertinent information available to abbott diabetes care has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 14 DAY
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key9351193
MDR Text Key167325218
Report Number2954323-2019-09149
Device Sequence Number1
Product Code PZE
Combination Product (y/n)N
PMA/PMN Number
P160030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup,Followup
Report Date 06/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number71940-01
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/01/2019
Initial Date FDA Received11/20/2019
Supplement Dates Manufacturer Received01/17/2020
05/28/2020
Supplement Dates FDA Received02/12/2020
06/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient Weight94
-
-